Literature DB >> 7565547

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.

.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7565547

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN： 1057-5987


× No keyword cloud information.
  17 in total

1.  Demographic characteristics and survival with AIDS: health disparities in Chicago, 1993-2001.

Authors:  Girma Woldemichael; Demian Christiansen; Sandra Thomas; Nanette Benbow
Journal:  Am J Public Health       Date:  2009-02-12       Impact factor: 9.308

2.  Effect of subspecialty training and experience on agreement with HIV guidelines.

Authors:  C R Horsburgh; F M Gordin; S Schaier; R Silver
Journal:  J Gen Intern Med       Date:  1997-08       Impact factor: 5.128

3.  Quality in HIV/AIDS care. Specialty-related or experience-related?

Authors:  W C Holmes
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

4.  Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

5.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

6.  Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012.

Authors:  John Weiser; Alejandro Perez; Heather Bradley; Hope King; R Luke Shouse
Journal:  Ann Intern Med       Date:  2017-12-26       Impact factor: 25.391

7.  CD4 Count in HIV- Brain-Dead Donors: Insight into Donor Risk Assessment for HIV+ Donors.

Authors:  Oscar Kenneth Serrano; Scott Kerwin; William D Payne; Timothy L Pruett
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

8.  CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1-infected Indian population: treatment implications.

Authors:  M Vajpayee; S Kaushik; V Sreenivas; N Wig; P Seth
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

9.  Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group.

Authors:  W Hughes; A Dorenbaum; R Yogev; B Beauchamp; J Xu; J McNamara; J Moye; L Purdue; R van Dyke; M Rogers; B Sadler
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group.

Authors:  D Torre; S Casari; F Speranza; A Donisi; G Gregis; A Poggio; S Ranieri; A Orani; G Angarano; F Chiodo; G Fiori; G Carosi
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.